By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Soligenix 

29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


SEARCH JOBS








Company News
Soligenix (SNGX) Announces Recent Accomplishments And Year-End 2016 Financial Results 3/27/2017 9:32:42 AM
Soligenix (SNGX) Receives European Patent For Formulation Of Synthetic Hypericin To Treat Psoriasis 2/22/2017 7:02:12 AM
Soligenix (SNGX) Announces SGX301 Receives Promising Innovative Medicine Designation From The UK Medicines And Healthcare Products Regulatory Agency 2/2/2017 8:14:18 AM
Soligenix (SNGX) Receives Positive Scientific Advice From The EMA For SGX942 In The Treatment Of Oral Mucositis In Head And Neck Cancer Patients 1/5/2017 8:52:28 AM
Soligenix (SNGX) Announces Extension of Development Agreement With Emergent BioSolutions (EBS) 1/3/2017 6:58:18 AM
Soligenix (SNGX) Advances Collaboration With IDT Biologika 12/20/2016 9:22:22 AM
Soligenix (SNGX) Announces Closing Of Public Offering 12/19/2016 9:48:43 AM
Soligenix (SNGX) Prices $5,277,000 Public Offering And Completes Listing On Nasdaq 12/13/2016 6:48:13 AM
Soligenix (SNGX) Announces SGX942 Receives Promising Innovative Medicine Designation From The UK Medicines And Healthcare Products Regulatory Agency 12/12/2016 7:56:13 AM
Soligenix (SNGX) Announces Positive Long-Term Follow-Up Results From Its Phase 2 Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients 12/8/2016 6:51:59 AM
12345678910...
//-->